Skip to content

Diminished Msh2 Expression C6055318

Published: July 22, 2026Updated: August 20, 2026

MSH2 is a key DNA mismatch repair gene. When its expression is reduced, cells accumulate genetic errors that can lead to tumor development. This is associated with Lynch syndrome and higher cancer risk, requiring surveillance and preventive strategies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Rectal bleeding

!

Unexplained weight loss

!

Iron deficiency anemia

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Persistent diarrhea

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enhanced endoscopic surveillance program

Annual colonoscopy with chromoendoscopy for high-quality visualization. Includes endometrial, ovarian, gastric, and urinary tract screening protocols.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Risk-reducing gynecologic surgery

Prophylactic hysterectomy and bilateral salpingo-oophorectomy after childbearing completed, significantly reducing endometrial and ovarian cancer risk in MSH2 carriers.

surgical

Additional treatment options

NSAID-based chemoprevention

Regular use of NSAIDs such as sulindac or celecoxib may reduce adenoma formation. Prescribed as adjunct to surveillance in high-risk individuals.

medication

Smoking cessation and alcohol moderation

Tobacco cessation critical as smoking significantly increases colorectal cancer risk in Lynch syndrome. Limiting alcohol to moderate levels reduces overall cancer burden.

lifestyle

Endoscopic polypectomy

Prompt removal of adenomatous polyps detected during surveillance colonoscopy. Complete resection reduces progression to invasive cancer.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Diminished Msh2 Expression C6055318?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Diminished Msh2 Expression C6055318. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy